Clinical Trial Update: To Evaluate the Safety and Efficacy of Remsima™ in Patients With Crohn's Disease (CD) or Ulcerative Colitis (UC)

View source ↗

Summary

Clinical trial update for Remsima in Crohn's disease and ulcerative colitis; study terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease
• Ulcerative Colitis

Drugs mentioned

• Remsima (infliximab)

Snippet

Sponsor: Celltrion | Conditions: Crohn's Disease, Ulcerative Colitis | Status: TERMINATED | Results posted: 2022-02-21